Desmoid Tumor Completed Phase 1 Trials for Tegavivint (DB17109)

Also known as: Desmoid-Type Fibromatosis / Desmoid Type-fibromatosis / Aggressive Fibromatosis / Desmoid tumour / Fibromatosis, Aggressive / Desmoid Tumors / Fibromatosis Desmoid / Desmoid Fibromatosis / Aggressive fibromatosis (disorder) / Aggressive fibromatosis (morphologic abnormality)

IndicationStatusPhase
DBCOND0028471 (Desmoid Tumor)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03459469Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059Treatment